Recently, Shenzhen Dahui Pet Medicine announced that it will deeply empower NovoHope, a pet functional food brand under Wuxi Nuohui Biotechnology, in its capacity as a shareholder and investor. Dahui Pet Medicine has officially signed a joint laboratory agreement with the Warshel Institute for Computational Biology at the Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen) to jointly advance technological research and development and the commercialization of achievements in the biotechnology field.
The Warshel Institute for Computational Biology is the first Nobel laureate laboratory at CUHK-Shenzhen, led and established by Professor Arieh Warshel, the winner of the 2013 Nobel Prize in Chemistry.The institute centers on the Nobel Prize-winning “multi-scale molecular simulation” method and possesses internationally leading scientific research capabilities in fields such as computational structural biology and computer-aided drug design. Professor Warshel is hailed as a “founder of computational biology,” and his pioneering research has provided crucial theoretical support for modern biomedical R&D.
As a strategic investor and shareholder of NovoHope, Dahui Pet Medicine injects Nobel-level scientific research resources into the brand through the joint laboratory.[cite: 5] Relying on the cutting-edge computing platform of the Warshel Lab, NovoHope will accurately explore active targets and mechanisms of action at the molecular level, providing rigorous scientific support for product development.
Wang (Dianjian), the founder of the brand, stated: “This cooperation marks a critical step for Dahui Pet Medicine and NovoHope in the integration of industry, academia, and research.Guided by the spirit of the Nobel Prize, we will continue to drive biotechnological innovation.”
0 Comments